Danielle E. Arnold, M.D.
- Center for Cancer Research
- National Cancer Institute
- Building 10-CRC, Room 1-5130
- Bethesda, MD 20892
- 240-281-3922
- danielle.arnold@nih.gov
RESEARCH SUMMARY
Dr. Arnold’s primary interest is to develop and optimize hematopoietic cell transplantation regimens for patients with primary immunodeficiencies and primary immune regulatory disorders. Her clinical focus at the NIH has been on patients with GATA2 deficiency, and she is developing a novel transplant regimen for GATA2 deficiency patients using an anti-c-kit antibody-based conditioning regimen. She is also investigating the role of autoinflammatory disease and transplant outcomes in patients with chronic granulomatous disease through her work with the Primary Immune Deficiency Treatment Consortium (PIDTC).
Areas of Expertise
Information for Patients
Learn more about our clinical trials and the highly specialized care teams that lead them.
Danielle E. Arnold, M.D.
Clinical Trials
Biography
Danielle E. Arnold, M.D.
Dr. Arnold received her medical degree from Columbia University College of Physicians & Surgeons and trained in pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt. She worked as a hospitalist on the Blood & Marrow Transplant service at Children’s Hospital of Philadelphia for two years after residency. She completed an allergy & immunology fellowship at Children’s Hospital of Philadelphia followed by a one-year immunodeficiency & bone marrow transplantation fellowship at Cincinnati Children’s Hospital Medical Center. Her research projects during fellowship focused on transplant outcomes for chronic granulomatous disease, immune reconstitution post-transplant, and characterization of virus-specific T cells. She joined the Immune-Deficiency Cellular Therapy Program in 2020.